Press Release

<< Back
Printer Friendly Version View printer-friendly version
Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in a fireside chat at the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12, 2017 at 11:10 a.m. ET in New York City.

A live webcast of the presentation will be available on the Investors & Media section of the Editas website at An archived replay will be available for approximately 30 days following the presentation.

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Cristi Barnett
Editas Medicine, Inc.
(617) 401-0113

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083

Primary Logo

Editas Medicine
Print Page    E-mail Page    RSS    E-mail Alerts